Latest Breaking News On - Wennian wu - Page 1 : vimarsana.com

BOSTON and CHENGDU, China, Jan. 08, 2024 (GLOBE NEWSWIRE) HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused o.

United statesShane maltbieRob hershbergWennian wuWang zhentaoPostdoctoral innovation practiceNational medical products administrationGroup ltdChengdu kanghua biological products co ltdTakeda vaccines incHillevax incMinistry of scienceMinistry of personnelExchange commissionInvestigational new drugChief executive officer